MyoGene Bio is awarded a Phase I SBIR grant from NIH

September 5, 2020

MyoGene Bio was awarded a Phase I SBIR grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases at the National Institutes of Health to advance preclinical studies. We are appreciative of their support!